164 related articles for article (PubMed ID: 29423787)
1. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
Zanetti HR; Roever L; Gonçalves A; Resende ES
Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787
[TBL] [Abstract][Full Text] [Related]
2. Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.
Bednasz C; Luque AE; Zingman BS; Fischl MA; Gripshover BM; Venuto CS; Gu J; Feng Z; DiFrancesco R; Morse GD; Ma Q
Curr Vasc Pharmacol; 2016; 14(3):280-7. PubMed ID: 26733388
[TBL] [Abstract][Full Text] [Related]
3. Effects of statins beyond lipid-lowering agents in ART-treated HIV infection.
Mehraj V; Chen J; Routy JP
Front Immunol; 2024; 15():1339338. PubMed ID: 38655259
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV.
Courlet P; Guidi M; Alves Saldanha S; Stader F; Traytel A; Cavassini M; Stoeckle M; Buclin T; Marzolini C; Decosterd LA; Csajka C;
Clin Pharmacokinet; 2021 Mar; 60(3):379-390. PubMed ID: 33124006
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of statin therapy among people living with HIV.
Boettiger DC; Kerr S; Chattranukulchai P; Siwamogsatham S; Avihingsanon A
AIDS; 2021 Mar; 35(4):567-574. PubMed ID: 33252492
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection.
Surma S; Banach M; Lewek J
Lipids Health Dis; 2021 Oct; 20(1):141. PubMed ID: 34689776
[TBL] [Abstract][Full Text] [Related]
7. Lipid management in patients who have HIV and are receiving HIV therapy.
Aberg JA
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):207-22. PubMed ID: 19217520
[TBL] [Abstract][Full Text] [Related]
8. Primary Prevention of Cardiovascular Disease for People Living with Human Immunodeficiency Virus.
Fox CB; Butler K; Flynn D
Nurs Clin North Am; 2024 Jun; 59(2):219-233. PubMed ID: 38670691
[TBL] [Abstract][Full Text] [Related]
9. CROI 2015: Complications of HIV Infection and Antiretroviral Therapy.
Havlir DV; Currier JS
Top Antivir Med; 2015; 23(1):56-65. PubMed ID: 25965312
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy is underutilized in people with HIV who could benefit from targeted lipid-lowering interventions.
Filip I
AIDS; 2024 Mar; 38(4):N7-N8. PubMed ID: 38194696
[No Abstract] [Full Text] [Related]
11. Use of HMG-CoA reductase inhibitors in the HIV population: implications for individualized treatment selection.
Advani A; Patel M; Pichardo RV; Whitty Y; Advani S
J Manag Care Spec Pharm; 2014 Mar; 20(3):262-72. PubMed ID: 24564807
[No Abstract] [Full Text] [Related]
12. Cardiovascular disease prevention in people living with HIV: from REPRIEVE to a statin of grace.
Vergallo R; Patrono C
Eur Heart J; 2023 Nov; 44(41):4308-4309. PubMed ID: 37674466
[No Abstract] [Full Text] [Related]
13. Intersection between Obesity, Dietary Selenium, and Statin Therapy in Brazil.
Watanabe LM; Navarro AM; Seale LA
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34204631
[TBL] [Abstract][Full Text] [Related]
14. Body-drug assemblages: theorizing the experience of side effects in the context of HIV treatment.
Gagnon M; Holmes D
Nurs Philos; 2016 Oct; 17(4):250-61. PubMed ID: 27435229
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1-mediated cardiac fibrosis: potential role in HIV and HIV/antiretroviral therapy-linked cardiovascular disease.
Ahamed J; Terry H; Choi ME; Laurence J
AIDS; 2016 Feb; 30(4):535-42. PubMed ID: 26605511
[TBL] [Abstract][Full Text] [Related]
16. Statin Reduces Heart Disease Risk in Patients With HIV.
Kuehn BM
Circulation; 2023 Sep; 148(13):1053-1054. PubMed ID: 37747955
[No Abstract] [Full Text] [Related]
17. Evidence of an anti-inflammatory effect of statins in people living with HIV.
Zureigat H; Abohashem S; Osborne MT; Lo J; Hsue P; Tawakol A
J Nucl Cardiol; 2022 Dec; 29(6):3069-3071. PubMed ID: 35277834
[No Abstract] [Full Text] [Related]
18. Challenges of Antiretroviral Treatment for Human Immunodeficiency Virus Infection in Pakistan.
Shah SA; Altaf A; Vermund SH
J Pak Med Assoc; 2021 Mar; 71(3):788-790. PubMed ID: 34057921
[No Abstract] [Full Text] [Related]
19. [Research progress on dyslipidemia related to human immunodeficiency virus infection].
Li L; Ma P
Zhonghua Nei Ke Za Zhi; 2024 Mar; 63(3):303-309. PubMed ID: 38448194
[TBL] [Abstract][Full Text] [Related]
20. HIV-associated dyslipidemia: pathogenesis and its management.
Wan Z; Dai B; Zhu X; Huang Y; Zhu B
Chin Med J (Engl); 2023 Nov; 136(22):2732-2734. PubMed ID: 37881960
[No Abstract] [Full Text] [Related]
[Next] [New Search]
